qfx

Analysts – those modern-day augurs – predict a compound annual growth rate of 16% for revenue and 18% for earnings per share through fiscal 2028. These figures, while ostensibly precise, are merely approximations – attempts to chart a course through a sea of infinite possibilities. The drivers of this growth – the increased adoption of Copilot, the deployment of advanced AI agents, the monetization of these emergent intelligences – are not simply technological advancements, but manifestations of a deeper, underlying force. To replace human workers with AI is not merely a matter of efficiency, but of accelerating the inevitable evolution of the species.

According to the official filings – and let’s be honest, reading SEC filings is not how most people choose to spend a Saturday afternoon – Caspian Capital increased its Bausch + Lomb holdings. The transaction itself bumped the value of their position by another $21.61 million, a sum that’s likely enough to make a few accountants do a little jig. It’s a decent bet, really. People will always need to see, even if what they’re looking at is just more quarterly reports.

Johnson & Johnson’s longevity – exceeding a century of operation – is frequently cited as a virtue. Such duration is, admittedly, unusual in the modern commercial landscape. It suggests a capacity to adapt, but also, perhaps, a certain institutional inertia. The company’s diversified portfolio – encompassing pharmaceuticals and medical devices – offers a degree of insulation against sector-specific shocks. However, diversification is not a guarantee of success; it merely spreads the risk.

0.09%. That’s the expense ratio. Less than a buck for every thousand you shove into this thing. It’s practically giving money away. You’re getting access to the whole oil and gas circus for pennies. ExxonMobil, Chevron – the big boys, the usual suspects – and everything downstream. Refineries, pipelines, the whole greasy, beautiful mess. It’s a low-cost ticket to a high-stakes game.

One observes a certain pruning of valuation, a necessary corrective, it seems, as investors weigh the potential for disruption—a ripple effect from distant conflicts. It is a curious thing, this market, how readily it responds to shadows cast by events unfolding continents away. Yet, let us not forget, even after this slight retraction, the stock has ascended a remarkable 357% over the past year—a testament to its inherent strength, or perhaps, a fleeting moment of exuberance.

For decades, we’ve been promised flying cars. Instead, we got…slightly better traffic jams. Self-driving cars? Still “just around the corner,” which, frankly, is starting to feel like a geographical impossibility. The problem isn’t the cars themselves, it’s the brains inside. Or, rather, the lack thereof. Sensors are expensive, regulations are…well, regulatory, and people are understandably hesitant to trust a vehicle controlled by algorithms. It’s like handing your life savings to a Roomba.